Evidence map›Paper›PMID 42889144›Full record

ReviewCurrent obstetrics and gynecology reports2026

Management of Recurrent Vaginitis.

Anna M Powell, Jack D Sobel, Christina A Muzny

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current obstetrics and gynecology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anna M PowellDepartment of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD USA.
Jack D SobelDivision of Infectious Diseases, Department of Medicine, Wayne State University, Detroit, MI USA.
Christina A MuznyDivision of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL USA.

Funding

Refining Trichomonas vaginalis treatment in women and men.R01AI183266 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI Patricia J Kissinger, Christina A Muzny · 2024 to 2026
$4.2M
Vaginal Microbiome and Metabolites in Preterm BirthK23AI155296 · NIAID · JOHNS HOPKINS UNIVERSITY · PI POWELL, ANNA MAYA · 2021 to 2025
$991k
NIAID NIH HHS K23 AI155296NIAID NIH HHS R01 AI183266
6 · The paper itself

Abstract

Purpose of Review: This review summarizes current evidence regarding the pathogenesis, diagnosis, and management of recurrent BV, recurrent VVC, and persistent trichomoniasis while highlighting emerging therapies and research priorities. Recent Findings: Recurrent BV is driven by persistence of a polymicrobial biofilm on vaginal epithelial cells, failure to restore a Summary: Recurrent vaginitis is a common and frustrating clinical problem that substantially impairs women's quality of life and accounts for frequent healthcare utilization. Although bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis (TV) share overlapping signs and symptoms, the mechanisms underlying recurrence differ considerably and require disease-specific management strategies.

Indexed as

Bacterial vaginosisRecurrent vaginitisTrichomonas vaginalisVaginal candidiasis

Identifiers

PMID42889144
PMCPMC13669020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.